Falcone, Mary
Liu, Lihua
Farias, Albert
Zhang, JuanJuan
Kang, Irene
Li, Ming
Stern, Mariana C.
Lerman, Caryn http://orcid.org/0000-0002-7553-8724
Funding for this research was provided by:
National Cancer Institute (HHSN261201800015I, HHSN261201800009I)
National Institutes of Health (R35 CA197461)
National Cancer Institute (P30 CA014089, HHSN261201800032I)
Article History
Received: 10 November 2020
Accepted: 27 January 2021
First Online: 6 March 2021
Compliance with ethical standards
:
: Dr. Kang is on the speaker’s bureau and served as a consultant for Puma Biotechnology, and has participated in an advisory board for Bristol-Myers Squibb. The other authors report nothing to disclose.
: This study was approved by the University of California Institutional Review Board.
: Informed consent was waived for this retrospective analysis of deidentified data.